Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia

Journal of Cellular Physiology

Volumn 226, Issue 11, 2011, Pages 2925-2933

  Yuan, Guoxiang ^a   Khan, Shakil A ^a   Luo, Weibo ^b   Nanduri, Jayasri ^a   Semenza, Gregg L ^b   Prabhakar, Nanduri R ^a  

^a University of Chicago   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; DIGOXIN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIFICIGUAT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN STEM; CAROTID BODY; CELL CULTURE; CELL STRAIN; CENTRAL NERVOUS SYSTEM; CEREBELLUM; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; HYPOXIA; MOUSE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANIMALS; ANOXIA; CAROTID BODY; CENTRAL NERVOUS SYSTEM; DEFEROXAMINE; DIGOXIN; ENZYME INHIBITORS; FIBROBLASTS; FURANS; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDAZOLES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NADPH OXIDASE; PC12 CELLS; PERIPHERAL NERVOUS SYSTEM; RATS; REACTIVE OXYGEN SPECIES; SIDEROPHORES; SLEEP APNEA SYNDROMES;

MUS;

EID: 79960697192     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22640     Document Type: Article

References (39)

1. Bao G, Metreveli N, Li R, Taylor A, Fletcher EC. 1997. Blood pressure response to chronic episodic hypoxia: Role of the sympathetic nervous system. J Appl Physiol 83: 95-101.
2. Bedard K, Krause KH. 2007. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87: 245-313.
3. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo J. 2009. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 10: 273-284.
4. Chen Z, Li Y, Zhang H, Huang P, Luthra R. 2010. Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 29: 4362-4368.
5. Del Rio R, Moya EA, Iturriaga R. 2010. Carotid body and cardiorespiratory alterations in intermittent hypoxia: The oxidative link. Eur Respir J 36: 143-150.
6. Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M, Devlin C, Blick C, Buffa F, Li JL, Vojnovic B, Pires das Neves R, Glazer P, Iborra F, Ivan M, Ragoussis J, Harris AL. 2010. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and Krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS ONE 5: e10345.
7. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL. 1999. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 59: 3915-3918.
8. Fletcher EC, Lesske J, Qian W, Miller CC III, Unger T. 1992. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19: 555-561.
9. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL. 2007. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129: 111-122.
10. 2 homeostasis by hypoxia-inducible factor 1a. Genes Dev 12: 149-162.
11. Khan S, Nanduri J, Yuan G, Kinsman B, Kumar GK, Joseph J, Kalyanaraman B, Prabhakar NR. 2010. Nox2 mediates intermittent hypoxia-induced mitochondrial complex I inhibition: Relevance to blood pressure changes in rats. Antioxid Redox Signal 14: 533-542.
12. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. 2006. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3: 177-185.
13. Kumar GK, Rai V, Sharma SD, Ramakrishnan DP, Peng YJ, Souvannakitti D, Prabhakar NR. 2006. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 575: 229-239.
14. Kuri BA, Khan SA, Chan SA, Prabhakar NR, Smith CB. 2007. Increased secretory capacity of mouse adrenal chromaffin cells by chronic intermittent hypoxia: Involvement of protein kinase C. J Physiol 584: 313-319.
15. Li JM, Shah AM. 2002. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 277: 19952-19960.
16. Li JM, Mullen AM, Shah AM. 2001. Phenotypic properties and characteristics of superoxide production by mouse coronary microvascular endothelial cells. J Mol Cell Cardiol 33: 1119-1131.
17. Mole DR, Blancher C, Copley RR, Pollard PJ, Gleadle JM, Ragoussis J, Ratcliffe PJ. 2009. Genome-wide association of hypoxia-inducible factor (HIF)-1a and HIF-2a DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem 284: 16767-16775.
18. Nanduri J, Wang N, Yuan G, Khan SA, Souvannakitti D, Peng YJ, Kumar GK, Garcia JA, Prabhakar NR. 2009. Intermittent hypoxia degrades HIF-2a via calpains resulting in oxidative stress: Implications for recurrent apnea-induced morbidities. Proc Natl Acad Sci USA 106: 1199-1204.
19. Narkiewicz K, Somers VK. 1997. The sympathetic nervous system and obstructive sleep apnea: Implications for hypertension. J Hypertens 15: 1613-1619.
20. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG. 2000. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283: 1829-1836.
21. Peng YJ, Prabhakar NR. 2004. Effect of two paradigms of chronic intermittent hypoxia on carotid body sensory activity. J Appl Physiol 96: 1236-1242.
22. Peng YJ, Overholt JL, Kline D, Kumar GK, Prabhakar NR. 2003. Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: Implications for recurrent apneas. Proc Natl Acad Sci USA 100: 10073-10078.
23. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL, Prabhakar NR. 2006. Heterozygous HIF-1a deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 577: 705-716.
24. Peng YJ, Nanduri J, Yuan G, Wang N, Deneris E, Pendyala S, Natarajan V, Kumar GK, Prabhakar NR. 2009. NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. J Neurosci 29: 4903-4910.
25. Peppard PE, Young T, Palta M, Skatrud J. 2000. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342: 1378-1384.
26. Poets CF, Samuels MP, Southall DP. 1994. Epidemiology and pathophysiology of apnoea of prematurity. Biol Neonate 65: 211-219.
27. Prabhakar NR, Kumar GK. 2010. Mechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxia. Respir Physiol Neurobiol 174: 156-161.
28. Semenza GL. 2009. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24: 97-106.
29. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A. 1996. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271: 32529-32537.
30. Souvannakitti D, Kumar GK, Fox A, Prabhakar NR. 2009. Neonatal intermittent hypoxia leads to long-lasting facilitation of acute hypoxia-evoked catecholamine secretion from rat chromaffin cells. J Neurophysiol 101: 2837-2846.
31. 2+ channels and ryanodine receptors mediate the augmented exocytosis of catecholamines from intermittent hypoxia-treated neonatal rat chromaffin cells. J Neurosci 30: 10763-10772.
32. Troncoso Brindeiro CM, da Silva AQ, Allahdadi KJ, Youngblood V, Kanagy NL. 2007. Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am J Physiol Heart Circ Physiol 293: H2971-H2976.
33. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514.
34. Yeo EJ, Chun YS, Cho YS, Kim J, Lee JC, Kim MS, Park JW. 2003. YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst 95: 516-525.
35. 2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem 280: 4321-4328.
36. 2+ signaling, prolyl hydroxylases, and mTOR. J Cell Physiol 217: 674-685.
37. Zhan G, Serrano F, Fenik P, Hsu R, Kong L, Pratico D, Klann E, Veasey SC. 2005. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 172: 921-929.
38. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, Gonzalez FJ, Semenza GL. 2008a. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 283: 10892-10903.
39. Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, Rey S, Hammers H, Chang D, Pili R, Dang CV, Liu JO, Semenza GL. 2008b. Digoxin and other cardiac glycosides inhibit HIF-1a synthesis and block tumor growth. Proc Natl Acad Sci USA 105: 19579-19586.